LINC01564

Across TCGA pan-cancer cohorts, LINC01564 RNA is linked to patient survival in 23 of 34 cancer types, making it the most broadly survival-associated LINC01564 data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher LINC01564 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC01564 expression acts as an unfavorable survival marker, although some lineages such as BLCA and MESO show a favorable association.

STAD, UCEC, and UVM are the cancer types where LINC01564 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	DFS	Tertile	All	0.233	0.494	<.001	97	view →
UCEC	DFS	Quartile	IV	0.146	0.575	.004	66	view →
UVM	DFS	Tertile	All	0.423	0.791	.015	45	view →
BLCA	DFS	Quartile	III,IV	0.589	0.173	.004	42	view →
MESO	OS	Median	All	0.645	0.470	.010	38	view →
BRCA	OS	Median	III,IV	0.752	0.893	.001	28	view →
OV	OS	Quartile	III,IV	0.753	0.657	.010	28	view →
HNSC	OS	Quartile	All	0.462	0.731	.009	25	view →
DLBC	DFS	Tertile	III,IV	0.070	0.855	.008	18	view →
LGG	OS	Median	All	0.928	0.862	<.001	14	view →
ACC	OS	Quartile	III,IV	0.168	0.526	.006	12	view →
SKCM	OS	Tertile	IV	0.179	0.727	<.001	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 23 lineages.

LINC01564–STAD (DFS)

Open the STAD breakdown →